Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia
Genetics in Medicine · 2023
DOI: 10.1016/j.gim.2023.100970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics in Medicine, 2023. Verfasst von Chi Kin Law und 9 weiteren Autor:innen. Beteiligte Einrichtung: NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia. Electronic address: chi.law@sydney.edu.au. Hauptthemen laut MEDLINE: Melanoma, Sunburn. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Medical Research Council, NHMRC, The University of Sydney.
Abstract (Originalsprache)
PURPOSE: Evidence indicates that a melanoma prevention program using personalized genomic risk provision and genetic counseling can affect prevention behaviors, including reducing sunburns in adults with no melanoma history. This analysis evaluated its longer-term cost-effectiveness from an Australian health system perspective. METHODS: The primary outcome was incremental cost effectiveness ratio (ICER) of genomic risk provision (intervention) compared with standard prevention advice. A decision-analytic Markov model was developed using randomized trial data to simulate lifetime cost-effectiveness. All costs were presented in 2018/19 Australian dollars (AUD). The intervention effect on reduced sunburns was stratified by sex and traditional risk, which was calculated through a validated prediction model. Deterministic and probabilistic sensitivity analyses were undertaken for robustness checks. RESULTS: The per participant cost of intervention was AUD$189. Genomic risk provision targeting high-traditional risk individuals produced an ICER of AUD$35,254 (per quality-adjusted life year gained); sensitivity analyses indicated the intervention would be cost-effective in more than 50% of scenarios. When the intervention was extended to low-traditional risk groups, the ICER was AUD$43,746 with a 45% probability of being cost-effective. CONCLUSION: Genomic risk provision targeted to high-traditional melanoma risk individuals is likely a cost-effective strategy for reducing sunburns and will likely prevent future melanomas and keratinocyte carcinomas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- NHMRC Clinical Trials Centre, The University of Sydney, Sydney, Australia. Electronic address: chi.law@sydney.edu.au.
- The Daffodil Centre, The University of Sydney, a joint venture with Cancer Council NSW, Sydney, Australia; Melanoma Institute Australia, The University of Sydney, Sydney, Australia; School of Public Health, The Universi…
- School of Public Health, The University of Sydney, Sydney, Australia.
- Sydney Medical School, The University of Sydney, Sydney, Australia.
- Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Sydney Medical School, The University of Sydney, Sydney, Australia.
- Melanoma Institute Australia, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Royal North Shore and Mater Hospitals, Sydney, Australia.
Förderung
- Medical Research Council
- NHMRC
- The University of Sydney
- Melanoma Institute Australia
Zitieren
APA
Law, C. K., Cust, A. E., Smit, A. K., Trevena, L., Fernandez-Penas, P., Nieweg, O. E., Menzies, A. M., Wordsworth, S., Morton, R. L., & Managing Your Risk Study Group (2023). Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia. Genetics in Medicine. https://doi.org/10.1016/j.gim.2023.100970
Vancouver
Law CK, Cust AE, Smit AK, Trevena L, Fernandez-Penas P, Nieweg OE, et al. Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia. Genetics in Medicine. 2023. doi:10.1016/j.gim.2023.100970
BibTeX
@article{Law2023,
author = {Law, Chi Kin and Cust, Anne E and Smit, Amelia K and Trevena, Lyndal and Fernandez-Penas, Pablo and Nieweg, Omgo E and Menzies, Alexander M and Wordsworth, Sarah and Morton, Rachael L and Managing Your Risk Study Group, Managing Your Risk Study Group},
title = {Long-term cost-effectiveness of a melanoma prevention program using genomic risk information compared with standard prevention advice in Australia},
journal = {Genetics in Medicine},
year = {2023},
doi = {10.1016/j.gim.2023.100970}
}
EUVIMED